Oct 4, 2017   SOURCE: PR NewsWire

Global Multiplex Biomarker Imaging Market to Touch US$ 843 Mn by 2027 - Future Market Insights

VALLEY COTTAGE, New York, October 4, 2017 /PRNewswire/ --

A new report published by FMI titled "Multiplex Biomarker Imaging Market: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)" studies the performance of the global multiplex biomarker imaging market over a ten year assessment period from 2017 to 2027. The report presents the value forecast of the global multiplex biomarker imaging market and provides key insights into the factors driving market growth as well as the factors restricting market growth. The estimates point to a revenue growth from about US$ 270 Mn in 2017 to nearly US$ 843 Mn by 2027 end, resulting in a CAGR of 12% over the forecast period.

(Logo: http://photos.prnewswire.com/prnh/20161020/430874LOGO )

  

Global Market Research Report Overview on Multiplex Biomarker Imaging @ https://www.futuremarketinsights.com/reports/multiplex-biomarker-imaging-market

Global Multiplex Biomarker Imaging Market: Segmentation and Forecast 

The global multiplex biomarker imaging market is segmented on the basis of component type, imaging technique, application and end-user.

The instrument segment is estimated to be valued at US$ 200.6 Mn in the year 2017 and is poised to reach a value of US$ 620.4 Mn at the end of the year 2027 and exhibit a CAGR of 12% during the period of assessment.

The software segment is estimated to be valued at US$ 41.2 Mn in the year 2017 and is slated to reach a value of US$ 133.2 Mn at the end of the year 2027 and exhibit a CAGR of 12.5% during the period of assessment.

View Report Table of Contents, Figures, and Tables@ https://www.futuremarketinsights.com/reports/multiplex-biomarker-imaging-market/toc

The IHC Assay segment is estimated to be valued at US$ 177.9 Mn in the year 2017 and is slated to reach a value of US$ 557.4 Mn at the end of the year 2027 and exhibit a CAGR of 12.1% during the period of assessment.

The FISH Assay segment is estimated to be valued at US$ 59.4 Mn in the year 2017 and is poised to reach a value of US$ 179.4 Mn at the end of the year 2027 and exhibit a CAGR of 11.7% during the period of assessment.

The research segment is estimated to be valued at US$ 238.6 Mn in the year 2017 and is poised to reach a value of US$ 740.5 Mn at the end of the year 2027 and exhibit a CAGR of 12% during the period of assessment.

The translational laboratories segment is estimated to be valued at US$ 4 Mn in the year 2017 and is slated to touch a value of US$ 418.2 Mn at the end of the year 2027 and exhibit a CAGR of 12.8% during the period of assessment.

A sample of this report is available upon request@ https://www.futuremarketinsights.com/reports/sample/rep-gb-3526

Global Multiplex Biomarker Imaging Market: Regional Forecast 

Future Market Insights tracks the performance of the global multiplex biomarker imaging market across the key geographies of North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan, and Middle East and Africa. As per the forecast of Future Market Insights, the North America multiplex biomarker imaging market is estimated to be valued at US$ 152.4 Mn in the year 2017 and is slated to touch a value of US$ 501.4 Mn at the end of the year 2027 and exhibit a CAGR of 12.6% during the assessment period. The Western Europe multiplex biomarker imaging market is estimated to be valued at US$ 64.7 Mn in the year 2017 and is poised to touch a value of US$ 208.6 Mn at the end of the year 2027 and exhibit a CAGR of 12.4% during the period of assessment.

Global Multiplex Biomarker Imaging Market: Vendor Insights 

The report has included some of the key players operating in the global multiplex biomarker imaging market such as Perkin Elmer, Inc., Bio-rad Laboratories Inc., Thermo Fisher Scientific, Inc., Abcam plc., Merck KGaA, Illumina Inc., Leica Biosystems Nussloch GmbH, Ventana Medical Systems, Inc., Aushon BioSystems Ltd., MicroConstants, Inc. and ToposNomos Ltd. Leading manufacturer of Multiplex Biomarker Imaging are focusing on collaborations with laboratories and biopharmaceutical companies in order to expand sales presence. Other companies are focusing on targeting technologically advanced emerging economies such as Asia Pacific region with availability of sufficient capital base and skilled labour.

Buy Multiplex Biomarker Imaging Market Report [https://www.futuremarketinsights.com/checkout/3526 ] 

About Us  

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends. 

            Contact Us 
        616 Corporate Way, Suite 2-9018, 
        Valley Cottage, NY 10989, 
        United States 
        T: +1-347-918-3531 
        F: +1-845-579-5705 
        T (UK): +44(0)20-7692-8790 
        Sales: sales@futuremarketinsights.com

  Website:  http://www.futuremarketinsights.com 


    Photo: 
    http://photos.prnewswire.com/prnh/20161020/430874LOGO

SOURCE Future Market Insights